Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

NCT04503707 · clinicaltrials.gov ↗

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Controlled Ovarian Stimulation

Interventions

DRUG: Follitropin Delta

Sponsor

Ferring Pharmaceuticals